Patent · US Active

Salts and crystals

US11440911B2 · kind B2 · utility

7Cited by

35References

5Claims

0Family size

Assignee

INTRA-CELLULAR THERAPIES, INC. · US

Inventors

Lawrence P. Wennogle · Fryeburg, US
Peng Li · New York, US
Edwin Aret · Almere, NL

Key dates

Filing date	Sep 26, 2018
Grant date	Sep 13, 2022
Priority date	—
Expiry date	Sep 26, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The disclosure provides new, stable, pharmaceutically acceptable hydrochloride salt forms of 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one, together with methods of making and using them, and pharmaceutical compositions comprising them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.